Fux, Michaela; Pecaric-Petkovic, T.; Odermatt, A.; Hausmann, Oliver; Lorentz, A.; Bischoff, S. C.; Virchow, J. C.; Dahinden, Clemens A. (2014). IL-33 is a mediator rather than a trigger of the acute allergic response in humans. Allergy, 69(2), pp. 216-222. Wiley-Blackwell 10.1111/all.12309
Text
,DanaInfo=.aoonlrjrpj0k2-M-x1vESw98+all12309.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (373kB) |
BACKGROUND
IL-33 enhances FcεRI-induced mediator release in human basophils without inducing degranulation itself. In contrast, studies in mice suggested that in the presence of high IgE levels, IL-33 triggers degranulation and anaphylaxis of similar severity as specific allergen. Consistent with this view, sera of atopic patients contain elevated levels of IL-33 after anaphylaxis. In this study, we determined whether IL-33 is potentially anaphylactogenic in humans with high IgE levels by regulating exocytosis independent of FcεRI cross-linking. Furthermore, we investigated whether IL-33 is released upon allergen provocation in vivo.
METHODS
In subjects with high serum IgE levels, we measured IL-33-induced histamine/LTC4 in vitro, CD63 translocation ex vivo, and responsiveness of mast cells in vivo by skin prick test (SPT). In asthma patients, release of IL-33 and its correlation with early (tryptase)- and late-phase markers (IL-13 levels, eosinophil numbers) of the allergic response were assessed in bronchoalveolar lavage fluids (BALFs) after allergen challenge.
RESULTS
IL-33 itself does not trigger basophil degranulation in vitro and ex vivo, even in subjects with high serum IgE levels, and negative SPTs demonstrate that skin mast cells do not degranulate in response to IL-33. However, in response to allergen challenge, IL-33 is rapidly released into BALFs at levels that do not correlate with other immediate- and late-phase parameters.
CONCLUSION
IL-33 is unlikely an independent trigger of anaphylaxis even in subjects with high IgE levels. However, the rapid release of IL-33 upon allergen provocation in vivo supports its role as a mediator of immediate allergic responses.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology and Immunology 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute for Immunology [discontinued] |
UniBE Contributor: |
Fux, Michaela, Pecaric, Tatjana, Hausmann, Oliver, Dahinden, Clemens A. |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0105-4538 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Stefan Kuchen |
Date Deposited: |
17 Jul 2014 16:45 |
Last Modified: |
05 Dec 2022 14:29 |
Publisher DOI: |
10.1111/all.12309 |
PubMed ID: |
24205920 |
Uncontrolled Keywords: |
IL-33, IgE, asthma, basophil/mast cell degranulation, bronchoalveolar lavage fluids |
BORIS DOI: |
10.7892/boris.42903 |
URI: |
https://boris.unibe.ch/id/eprint/42903 |